ACADIA Pharmaceuticals Inc (ACAD) — Financial Flexibility Index
ACADIA Pharmaceuticals Inc (ACAD) has a Financial Flexibility Index of 0.33x as of June 2026. Free cash flow of $145.06 Million (operating CF $134.76 Million minus capex $10.30 Million) represents 0% of total liabilities ($436.29 Million). Check ACADIA Pharmaceuticals Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ACADIA Pharmaceuticals Inc Financial Flexibility Index (2002–2025)
Historical Financial Flexibility Index trend for ACADIA Pharmaceuticals Inc across 24 annual periods. For the full cash flow conversion analysis, see cash flow conversion of ACADIA Pharmaceuticals Inc.
Annual Financial Flexibility Index for ACADIA Pharmaceuticals Inc (2002–2025)
Year-by-year free cash flow to debt coverage for ACADIA Pharmaceuticals Inc. Explore ACADIA Pharmaceuticals Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.34x | $114.53 Million | $109.84 Million | $336.81 Million | ▼ -2.2% |
| 2024 | 0.35x | $158.24 Million | $157.72 Million | $454.96 Million | ▲ +94.4% |
| 2023 | 0.18x | $56.75 Million | $16.70 Million | $317.20 Million | ▲ +129.4% |
| 2022 | -0.61x | $-114.03 Million | $-114.03 Million | $187.40 Million | ▲ +22.2% |
| 2021 | -0.78x | $-124.54 Million | $-125.66 Million | $159.23 Million | ▲ +5.3% |
| 2020 | -0.83x | $-128.58 Million | $-136.17 Million | $155.61 Million | ▲ +53.7% |
| 2019 | -1.78x | $-150.00 Million | $-151.13 Million | $84.05 Million | ▲ +34.0% |
| 2018 | -2.70x | $-165.32 Million | $-167.47 Million | $61.12 Million | ▲ +38.7% |
| 2017 | -4.41x | $-217.04 Million | $-217.86 Million | $49.22 Million | ▲ +6.2% |
| 2016 | -4.70x | $-200.90 Million | $-210.41 Million | $42.74 Million | ▲ +13.1% |
| 2015 | -5.41x | $-119.65 Million | $-121.80 Million | $22.13 Million | ▼ -30.3% |
| 2014 | -4.15x | $-66.25 Million | $-66.43 Million | $15.97 Million | ▲ +6.9% |
| 2013 | -4.46x | $-31.15 Million | $-31.77 Million | $6.99 Million | ▼ -386.6% |
| 2012 | -0.92x | $-21.63 Million | $-21.63 Million | $23.61 Million | ▲ +59.7% |
| 2011 | -2.27x | $-19.89 Million | $-19.90 Million | $8.75 Million | ▼ -84.9% |
| 2010 | -1.23x | $-10.70 Million | $-10.70 Million | $8.71 Million | ▼ -237.4% |
| 2009 | -0.36x | $-13.69 Million | $-13.73 Million | $37.57 Million | ▲ +93.4% |
| 2008 | -5.53x | $-64.64 Million | $-64.87 Million | $11.69 Million | ▼ -109.6% |
| 2007 | -2.64x | $-54.51 Million | $-54.93 Million | $20.65 Million | ▼ -50.0% |
| 2006 | -1.76x | $-39.39 Million | $-41.42 Million | $22.39 Million | ▼ -111.6% |
| 2005 | -0.83x | $-19.24 Million | $-20.26 Million | $23.13 Million | ▲ +59.9% |
| 2004 | -2.08x | $-20.11 Million | $-20.69 Million | $9.68 Million | ▼ -2078.9% |
| 2003 | -0.10x | $-8.04 Million | $-9.82 Million | $84.36 Million | ▲ +39.7% |
| 2002 | -0.16x | $-8.86 Million | $-9.24 Million | $56.11 Million | — |